Early detection and diagnosis (ED&D) research seeks to detect and diagnose consequential precancerous changes and cancer at the earliest possible point at which an intervention might be made, reducing ...

Please note - this trial is no longer recruiting patients. We hope to add results when they are available. After treatment you see your doctor regularly to make sure the cancer isn’t coming back. If ...

Not everyone with eye cancer will have changes in sexual desire or how they feel about themselves sexually. You might not notice any changes at all. But you might find cancer changes your body image ...

This trial is looking at a drug called MK-5684 for people with prostate cancer that has spread to another part of the body and has started to grow again. Read more about A trial looking at a drug ...

Cancer (excluding benign, uncertain and unknown behaviour brain, other CNS and intracranial tumours) is the second most common cause of death for males and females aged 15-24. Cancer accounted for 10% ...

How do atezolizumab and bevacizumab work? Atezolizumab is a type of immunotherapy called a monoclonal antibody. It works by binding to PD-L1 proteins on the surface of cancer cells. This stops cancer ...

Our second Cancer Prevention Research Conference includes three days of scientific sessions, networking, panel discussions and much more.

Every step we make towards beating cancer relies on every pound, every hour and every person. Be a part of Taunton & District fundraising group; raising awareness and life-saving funds to help beat ...

You can choose whether to go for cervical screening. Some people are worried about having the test. Finding out what will happen at your appointment can help. You can also consider where you want to ...

Being aware of the groups that are less likely to attend screening will support you to target and tailor interventions. The following groups of people may be less likely to take up breast screening: 1 ...

The appropriate age bracket to offer breast screening is often debated, as there is limited evidence on the benefits and harms of screening before the age of 50 and after the age of 70. Before any ...

Breast cancer is the most common cancer in the UK. 1 in 7 women will be diagnosed with breast cancer in their lifetime, which is the second most common cause of cancer death for women 1 ...